Insider Sale: CEO Edward M. Kaye of Stoke Therapeutics Inc (STOK) Sells 42,350 Shares

Yahoo FinanceMay 22 19:07 ET

Stoke Therapeutics(STOK.US) Officer Sells US$769.5K in Common Stock

$Stoke Therapeutics(STOK.US)$ Officer Nash Huw M. sold 50,000 shares of common stock on May 20, 2024 at an average price of $15.39 for a total value of $769.5K.Source: Announcement What is statement o

moomoo NewsMay 22 17:03 ET

Stoke Therapeutics(STOK.US) Officer Sells US$653.53K in Common Stock

$Stoke Therapeutics(STOK.US)$ Officer Kaye Edward M. MD sold 42,350 shares of common stock on May 20, 2024 at an average price of $15.4316 for a total value of $653.53K.Source: Announcement What is st

moomoo NewsMay 22 17:01 ET

Stoke Therapeutics(STOK.US) Officer Sells US$129.33K in Common Stock

$Stoke Therapeutics(STOK.US)$ Officer Allan Jonathan sold 8,599 shares of common stock on May 20, 2024 at an average price of $15.0398 for a total value of $129.33K.Source: Announcement What is statem

moomoo NewsMay 22 16:59 ET

Stoke Therapeutics Insider Sold Shares Worth $653,529, According to a Recent SEC Filing

Edward M. Kaye, Director, CEO, on May 20, 2024, sold 42,350 shares in Stoke Therapeutics (STOK) for $653,529. Following the Form 4 filing with the SEC, Kaye has control over a total of 27,000 shares o

MT NewswiresMay 22 16:25 ET

Form 144 | Stoke Therapeutics(STOK.US) Officer Proposes to Sell 119.53K in Common Stocks

SEC FILLINGS DISCLOSED/ May 20, $Stoke Therapeutics(STOK.US)$ Officer JONATHAN ALLAN intends to sell 8,599 shares of its common stock on May 20, with a total market value of approximately $119.53K.

moomoo NewsMay 20 16:29 ET